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Multipotent neural progenitor cells (NPCs) undergo self-renewal while producing neurons, astrocytes, and
oligodendrocytes. These processes are controlled by multiple basic helix-loop-helix (bHLH) fate determina-
tion factors, which exhibit different functions by posttranslational modifications. Furthermore, depending on
the expression dynamics, each bHLH factor seems to have two contradictory functions, promoting NPC
proliferation and cell-cycle exit for differentiation. The oscillatory expression of multiple bHLH factors
correlates with the multipotent and proliferative state, whereas sustained expression of a selected single
bHLH factor regulates the fate determination. bHLH factors also regulate direct reprogramming of adult
somatic cells into neurons and oligodendrocytes. Thus, bHLH factors play key roles in development and
regeneration of the nervous system. Here, we review versatile functions of bHLH factors, focusing on telen-
cephalic development.Introduction
During the course of development, neural progenitor cells
(NPCs) are responsible for generating the diverse types of neu-
rons and glial cells that build the nervous system (McConnell,
1995; Okano and Temple, 2009; Breunig et al., 2011). In the
developing telencephalon, NPCs of the lateral ventricular wall
undergo changes in morphology and property and produce
different progeny as brain development proceeds (Fishell and
Kriegstein, 2003; Kriegstein and Alvarez-Buylla, 2009). Neuroe-
pithelial cells, the earliest form of NPCs, constitute a single layer
of pseudostratified columnar epithelium (Figure 1). Neuroepithe-
lial cells are gradually transformed into elongated radial glial (RG)
cells that span the thickness of the brain wall, retaining their cell
bodies in the innermost layer, called the ventricular zone (VZ)
(Figure 1). RG cells undergo asymmetric cell division: each RG
cell divides into two distinct cell types, one RG cell and one
immature neuron or an intermediate progenitor (Go¨tz and Hutt-
ner, 2005; Miller and Gauthier, 2007). Immature neurons migrate
out of the VZ into the outer layers, where they become mature
neurons, while intermediate progenitors migrate into the subven-
tricular zone (SVZ), proliferate further, and give rise to more neu-
rons (Figure 1). Thus, the SVZ is a secondary germinal zone
where further divisions of intermediate progenitors occur to
enlarge the neuronal populations. Neocortical NPCs also give
rise to a new type of RG cells, known as outer RG cells, whose
cell bodies are located in the outer VZ (Figure 1) (Hansen et al.,
2010; Fietz et al., 2010; Wang et al., 2011; Shitamukai et al.,
2011). After producing neurons, RG cells finally differentiate
into glial cells, but some of them are maintained as NPCs in
the postnatal and adult brain.It has been shown that basic helix-loop-helix (bHLH) factors
play key roles in self-renewal of NPCs and fate determination of
neurons, oligodendrocytes, and astrocytes (Figure 2) (Bertrand
et al., 2002;Rosset al., 2003;Meijer et al., 2012;Namihira andNa-
kashima, 2013). Repressor bHLH factors like Hes1 regulate the
self-renewal of NPCs, whereas proneural bHLH factors, such as
Ascl1 (also called Mash1) and Neurog2, promote neuronal differ-
entiation.Other bHLH factors,Olig1 andOlig2, regulate oligoden-
drocyte differentiation,whileHes1 induces astrocyte formation at
later stages. Thus, bHLH factors play key roles in all these steps
(Figure 2), but recent studies revealed that the regulation is not
that simple. Below, we discuss the recent findings regarding the
complex regulations and functions of these bHLH factors.
bHLH Factors in Telencephalic Development
Maintenance of NPCs by Notch-Hes Signaling
To develop the nervous system with the appropriate number of
neurons and glia, it is essential that NPCs and intermediate pro-
genitors proliferate sufficiently prior to differentiating (Caviness
et al., 1995; Kriegstein and Alvarez-Buylla, 2009). In addition, a
sufficient number of NPCs must be maintained until adulthood
in the SVZ of the lateral ventricles and the hippocampal dentate
gyrus, as they are important for higher brain functions such
as learning and memory. Thus, the maintenance of NPCs
throughout life is essential for brain morphogenesis and func-
tions. NPCs are maintained in an undifferentiated state by
bHLH factors, such as Hes, Hey, and Id family members. Hes1
and Hes5 are widely expressed by NPCs in the VZ of the devel-
oping telencephalon. In addition, Hes3 is expressed at early
stages in the developing nervous system.Neuron 82, April 2, 2014 ª2014 Elsevier Inc. 9
Figure 1. Neural Progenitor Cells in the Developing Telencephalon
MZ, Marginal zone; UL, upper layer; LL, lower layer; SVZ, subventricular zone;
VZ, ventricular zone.
Figure 2. Simplified Roles of bHLH Factors in NPC Self-Renewal and
Cell Fate Determination
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ments (i.e., N-box, E-box, or C-site) to repress the expression
of target genes (Figure 3Aa) (Sasai et al., 1992). Although there
are many downstream targets of Hes factors, proneural genes
are the most important targets in the context of neural develop-
ment. Hes factors directly repress the expression of proneural
genes, such as Ascl1 and Neurog2, and in the absence of Hes
genes, proneural gene expression is upregulated, accelerating
neurogenesis (Hatakeyama et al., 2004; Imayoshi et al., 2008).
Hes factors can also antagonize the activity of proneural bHLH
proteins by physical interaction: the Hes-proneural bHLH com-
plex can bind and repress neuronal target genes, resulting in
the inhibition of neurogenesis (Figure 3Ab) (Giagtzoglou et al.,
2003). Thus, Hes factors inhibit neurogenesis by antagonizing
proneural factors via two independent mechanisms: direct tran-
scriptional repression and physical interaction.
Hes factors cooperatively regulate NPC maintenance and
therefore only in compound Hes knockout mice do severe de-
fects of NPCmaintenance occur. InHes1;Hes5 double knockout
mice, the expression of proneural factors is upregulated, leading
to severe premature neuronal differentiation, rapid depletion of
NPCs, and disorganized structures of the developing nervous
system (Ohtsuka et al., 1999; Hatakeyama et al., 2004). Even
more severe and wider defects of premature neurogenesis and
depletion of NPCs occur in the Hes1;Hes3;Hes5 triple knockout
mice (Hatakeyama et al., 2004). However, in the developing
telencephalon, NPCs are maintained and proliferate almost nor-
mally even in the absence of Hes1, Hes3, and Hes5 (Imayoshi
et al., 2008), indicating that the requirement for Hes factors is
different between the telencephalon and other regions. In the
developing telencephalon, Hey1 is highly expressed, and this
expression is upregulated in the absence of Hes1, Hes3, and
Hes5 (Imayoshi et al., 2008), suggesting that Hey1 may compen-
sate for Hes factors to regulate telencephalic development.
Further evidence of the role of Hes factors in the maintenance
of NPCswas obtained by overexpression studies, which showed
that Hes factors inhibit neurogenesis and increase the proportion10 Neuron 82, April 2, 2014 ª2014 Elsevier Inc.of undifferentiated NPCs (Ishibashi et al., 1994; Ohtsuka et al.,
2001).
In the developing nervous system, proneural factors, such as
the bHLH transcription activators Ascl1, Neurog1, and Neurog2,
induce neuronal differentiation (Figure 2, see below) (Bertrand
et al., 2002;Wilkinson et al., 2013). These factors also upregulate
the expression of ligands for Notch signaling, such as the trans-
membrane proteins Delta-like1 (Dll1) and Jagged1 (Jag1), which
activate the transmembrane protein Notch in neighboring cells
(Castro et al., 2006; D’Souza et al., 2008; Henke et al., 2009).
Upon activation of Notch, the Notch intracellular domain
(NICD) is released from the transmembrane portion and trans-
ferred to the nucleus, where it forms a complex with the DNA-
binding protein RBPjk and the coactivator Mastermind-like
(Maml) (Kopan and Ilagan, 2009). The NICD-RBPjk-Maml com-
plex is a transcriptional activator and induces the expression of
bHLH transcriptional repressors, such as Hes1 and Hes5,
constituting a so-called canonical pathway. By contrast, Hes3
expression is induced by a noncanonical pathway of Notch
signaling (Androutsellis-Theotokis et al., 2006). Hes factors
then repress the expression of proneural genes andDll1, thereby
inhibiting neuronal differentiation and promoting the mainte-
nance of NPCs. Thus, differentiating neurons inhibit neighboring
cells from differentiating into the same cell type via Notch
signaling, a process called lateral inhibition. This lateral inhibition
prevents simultaneous differentiation of all NPCs, thereby
achieving prolonged NPC maintenance into later stages of
development (Imayoshi et al., 2010). Besides Notch signaling,
Hes5 expression is upregulated by Gcm genes (Hitoshi et al.,
2011). By contrast, in differentiating neurons, even though Notch
signaling is activated, Hes5 expression is suppressed by Bcl6,
which excludes the coactivator Maml1 from NICD and recruits
the histone deacetylase Sirt1 to the Hes5 promoter, thereby re-
inforcing neuronal differentiation (Tiberi et al., 2012). Thus, Hes
expression is controlled at multiple levels.
In addition to Hes factors, Id factors are expressed by NPCs in
the developing brain. In Id1;Id3 double knockoutmice, NPCs exit
the cell cycle prematurely and undergo accelerated neuronal
differentiation (Lyden et al., 1999). Thus, Id factors inhibit
Figure 3. Mechanisms of bHLH Factor
Regulation
(A) bHLH factors activate or repress gene expres-
sion by physically interacting with each other.
(B) Phosphorylation-dependent modulation of
transcriptional activity of proneural factors.
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overexpression of Ids in NPC culture blocks neurogenesis, indi-
cating that Id factors are sufficient for NPC maintenance
(Figure 2) (Bai et al., 2007). Id factors form dimers with and
sequester E proteins away from proneural bHLH proteins.
Because Id proteins lack the basic DNA binding motif, the Id/E
heterodimer complex cannot bind to DNA (Figure 3Ac). There-
fore, Id factors function as dominant-negative antagonists of
proneural bHLH transcription factors (Perk et al., 2005). Unlike
Hes1, Id expression is not activated by Notch signaling but
strongly regulated by bone morphogenetic protein (BMP) sig-
naling (Nakashima et al., 2001; Mira et al., 2010).
Proneural Factors for Neurogenesis
In the developing and postnatal brain, proneural bHLH factors
are key regulators of neurogenesis, coordinating a generic
neuronal fate and a specific subtype identity (Bertrand et al.,Neu2002; Wilkinson et al., 2013). These fac-
tors are transcriptional activators that
bind to target DNA sequences as hetero-
dimer complexes with ubiquitously ex-
pressed bHLH E proteins (E12, E47,
HEB, or E2-2) (Figure 3Ad). Target genes
for proneural factors include those encod-
ing Notch ligands, such as Dll1, which
activate Notch signaling in neighboring
cells (Castro et al., 2006; Henke et al.,
2009). Thus, proneural factors are com-
ponents of the intercellular regulation
of Notch signaling, contributing to NPC
maintenance. Proneural factors and
Notch ligands are expressed in NPCs, as
well as in intermediate progenitors and
immature neurons, all of which send
Notch signaling inputs to neighboring
NPCs in the germinal zone (Nelson et al.,
2013).
There is also evidence that Ascl1
directly promotes proliferation of NPCs,
in addition to cell-cycle exit and differenti-
ation, highlighting themultiple functions of
proneural factors (Castro et al., 2011).
Chromatin immunoprecipitation (ChIP)-
chip analysis revealed that Ascl1 directly
regulates the genes involved in cell-cycle
exit, neurotransmitter biosynthesis, and
neurite outgrowth, as expected. However,
unexpectedly, this analysis also showed
that Ascl1 directly regulates the genes
involved in cell-cycle progression, in-
cluding those essential for the G1/Stransition and entry into mitosis. Furthermore, when Ascl1 is
acutely inactivated, NPCs in the VZ and the SVZ exit the cell
cycle prematurely (Castro et al., 2011). These results indicate
that Ascl1 promotes the expansion of NPCs as well as their
subsequent cell-cycle exit and neuronal differentiation. This
contradictory dual activity seems to have been evolutionally
conserved, because the Drosophila Ascl1 ortholog Asense pro-
motes self-renewal of neuroblasts but inhibits proliferation of
neuroblast daughter cells (Wallace et al., 2000; Southall and
Brand, 2009).
Dynamic Regulation of Proneural bHLH Factors
The expression of proneural factors, such as Ascl1 and Neurog2,
seems to be dynamically controlled at both the mRNA and pro-
tein levels. In NPCs, the RNase III Drosha destabilizes Neurog2
mRNA in a microRNA-independent manner by recognizing the
hairpin structures of 30 UTR of Neurog2 mRNA. Therefore,ron 82, April 2, 2014 ª2014 Elsevier Inc. 11
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stabilization of Neurog2 mRNA (Knuckles et al., 2012), sug-
gesting that a reduction in Drosha activity regulates the onset
of neuronal differentiation. In addition, Neurog1/2 proteins
have short half-lives, less than 30 min, which, along with their
proneural activity, are dynamically controlled in NPCs and inter-
mediate progenitors (Ali et al., 2011; Hindley et al., 2012). In the
mouse Neurog2 protein, nine serine-proline sites are subjected
to phosphorylation by Cyclin-dependent kinases (CDKs). When
the overall phosphorylation state is increased, the protein sta-
bility, DNA binding to the E-box, and neuronal differentiation
potency are diminished, indicating that cell-cycle machinery
negatively regulates neurogenesis through the phosphorylation
of Neurog2 protein. Indeed, an unphosphorylated form of
Neurog2 can more efficiently activate expression of the neu-
ronal differentiation gene Neurod1 than can the phosphorylated
form (Figure 3B, bottom). However, this transcriptional activity
is promoter specific, and both phosphorylated and unphos-
phorylated forms can similarly activate expression of the Notch
ligand Dll1 (Figure 3B, top). A recent study showed that gly-
cogen synthase kinase 3 (GSK3) also regulates Neurog2 pro-
neural activity in the developing neocortex (Li et al., 2012).
Threonine-proline phosphorylation by GSK3 inhibits the tran-
scriptional activity of Neurog2 by preventing the dimer forma-
tion. Interestingly, early stage cortical NPCs have low levels of
GSK3 activity, whereas at later embryonic periods GSK3 is pro-
gressively activated in cortical NPCs. Indeed, the proneural
activity of Neurog2 is stronger in early stage cortical progenitors
than in later stages, oppositely correlating with GSK3 activity (Li
et al., 2012).
Ascl1 protein also seems to be destabilized in NPCs. It was
reported that NICD induces ubiquitin-proteasome-dependent
rapid degradation of Ascl1 protein with a half-life of just 14 min
in human cells (Sriuranpong et al., 2002). However, Ascl1 is sta-
bilized when NICD is absent (half-life is 50 min) (Sriuranpong
et al., 2002), suggesting that this stabilization leads to accumu-
lation of Ascl1 protein, thereby promoting neuronal differentia-
tion. Furthermore, posttranslational modification is important
for Ascl1 protein stability. Nonphosphorylated Ascl1 protein
is very unstable, whereas CK2-mediated phosphorylation of
S152 stabilizes Ascl1 protein (Vin˜als et al., 2004).
Neurog1 and Neurog2 expression is restricted to the dorsal
telencephalon, which gives rise to pyramidal cells (glutamatergic
neurons), whereas Ascl1 is predominantly expressed in the
ventral telencephalon, which gives rise to cortical interneurons
(GABAergic neurons), suggesting that proneural factors also
contribute to specification of neuronal subtype identities.
Indeed, in the dorsal telencephalon, loss- and gain-of-function
studies have revealed that Neurog1 and Neurog2 are necessary
and sufficient to specify a glutamatergic neuronal identity (Fode
et al., 2000; Parras et al., 2002; Schuurmans et al., 2004; Mattar
et al., 2004, 2008; Britz et al., 2006; Kovach et al., 2013). In the
ventral telencephalon, similar studies have revealed that Ascl1
is necessary and sufficient to specify a GABAergic interneuron
identity (Casarosa et al., 1999; Horton et al., 1999; Berninger
et al., 2007; Poitras et al., 2007). Below, we summarize how pro-
neural bHLH factors contribute to the specification of distinct
neuronal cell fates.12 Neuron 82, April 2, 2014 ª2014 Elsevier Inc.Glutamatergic Neuronal Specification by Neurogenins
Neurog1 and Neurog2 are expressed in the developing dorsal
telencephalon, which includes the anlagen of the neocortex
and hippocampus. Essential roles of Neurog1/2 in neocortical
development were revealed by loss-of-function studies (Schuur-
mans and Guillemot, 2002). The formation of cortical projection
neurons is severely impaired in Neurog2 and Neurog1/2 dou-
ble-mutant mice. Furthermore, the number of Cajal-Retzius neu-
rons, a layer I cortical population, is diminished in Neurog2
mutant mice (Imayoshi et al., 2008; Dixit et al., 2014). Defects
of fate specification of layer V and VI early-born neurons to glu-
tamatergic neurons are most evident in the absence of Neurog2
(Schuurmans et al., 2004). The production of hippocampal pro-
jection neurons and dentate granule cells is also affected in
Neurog2mutant mice (Galichet et al., 2008). Conversely, overex-
pression studies provided evidence for the sufficiency of
Neurog1/2 in the fate specification of these glutamatergic neu-
rons (Mattar et al., 2004, 2008; Kovach et al., 2013). Thus,
Neurog1/2 are necessary and sufficient to specify glutamatergic
neurons throughout telencephalic development. Interestingly,
Neurog1/2 repress the differentiation program of GABAergic
neurons. In the dorsal telencephalon of Neurog1/2 double- and
even Neurog2 single-mutant mice, misexpression of Ascl1 and
many GABAergic neuronal markers, such as Dlx, Gad1/2,
and VGAT, occurs (Schuurmans et al., 2004). Furthermore, in
the knockin mice, in which the coding region of the Neurog2
locus was swapped for the Ascl1 sequence, dorsal cortical pro-
genitors are misdirected toward the GABAergic neuronal fate
(Fode et al., 2000).
In the dorsal telencephalon, RG cells express the homeodo-
main transcription factor Pax6, whereas intermediate progeni-
tors express the T-box transcription factor Tbr2. Most cortical
pyramidal neurons are generated via Tbr2-positive intermediate
progenitors, and these cells typically go through one round of
cell division (Go¨tz and Huttner, 2005). This division is believed
to increase the neuronal population of the neocortex. It was
shown that Neurog2 directly regulates expression of Tbr2 and
that Neurog2 is necessary and sufficient to promote the transi-
tion of RG cells to intermediate progenitors (Ochiai et al.,
2009). Neuronal differentiation is tightly coupled with cell-cycle
exit, and it is likely that increased expression of Neurog1/2 leads
to gradual accumulation of cell-cycle inhibitors, such as p21
(Cip1), p27 (Kip1), p57 (Kip2), and BM88 (Cend1) (Politis et al.,
2007; Lange et al., 2009). Interestingly, p27 also promotes neu-
rogenesis by stabilizing Neurog2 protein through direct interac-
tion (Nguyen et al., 2006).
Neuronal migration is critical for establishing neocortical cell
layers, and migration defects can cause neurological and psy-
chiatric diseases. Neurog2 is important for the radial migration
of cortical pyramidal neurons by regulating the formation of
neuronal polarity and development of a leading process. It was
found that RhoA inhibits neuronal migration by tight regulation
of F-actin polymerization and microtubule assembly. Neurog2
enhances neuronal migration, independently of its proneural
activity, but by activating Rho-GAP expression via C-terminal
tyrosine (Y241) phosphorylation that leads to inhibition of RhoA
activity (Hand et al., 2005). Furthermore, Neurog2 promotes
neuronal migration by upregulating the expression of Rnd2, an
Neuron
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tion (Heng et al., 2008). Thus, Neurog2 can promote neuronal
migration by inhibiting RhoA activity via two independent mech-
anisms: Y241 phosphorylation and Rnd2 induction.
After glutamatergic neuronal specification by Neurog1/2,
terminal differentiation of cortical and hippocampal neurons
are regulated by other bHLH factors. Transient expression of
Neurog1/2 in NPCs and early-phase intermediate progenitors in-
duces the subsequent expression of bHLH gene cascades, such
as those encoding NeuroD1/2/4/6, bHLHb5, Nscl1/2, andMath6
(so-called bHLH differentiation factors) (Mattar et al., 2004, 2008;
Kovach et al., 2013). As in the case of proneural bHLH factors,
overexpression of bHLH differentiation factors induces neuronal
differentiation and cell-cycle exit. Like proneural bHLH factors,
bHLH differentiation factors specifically bind to E-box con-
sensus sequences and activate downstream gene expression.
These bHLH differentiation factors redundantly regulate various
maturation processes of glutamatergic neurons, such as migra-
tion, polarization, axon and dendrite maturation, survival, and
synaptic formation. Thus, neuronal differentiation and matura-
tion defects are evident only in compound mutants of these fac-
tors (Schwab et al., 2000).
GABAergic Neuronal Specification by Ascl1
Ascl1 is predominantly expressed by NPCs in the ventral telen-
cephalon, such as in the medial, lateral, and caudal ganglionic
eminences. It is known that GABAergic inhibitory neurons are
born in the germinal zone of the ganglionic eminence and
tangentially migrate to the neocortex. In Ascl1 knockout mice,
the production of GABAergic neurons is massively attenuated
(Casarosa et al., 1999; Horton et al., 1999), whereas overexpres-
sion of Ascl1 induces ectopic production of GABAergic neurons
from dorsal cortical NPCs (Berninger et al., 2007; Poitras et al.,
2007). In Ascl1 knockout mice, defects in interneuron production
are the most pronounced in the medial ganglionic eminence,
whereas striatal neuronal formation occurs normally in the lateral
ganglionic eminence, suggesting that other factors can substi-
tute for Ascl1 in the generation of striatal neurons. Indeed, striatal
development is severely affected inAscl1;Gsx2 double knockout
mice (Wang et al., 2009). Conversely, transient accumulation of
Ascl1 in NPCs and early-phase progenitors induces the subse-
quent expression of GABAergic differentiation gene cascades,
such as those encoding Dlx1/2/5/6 and Lhx6 (Yun et al., 2002;
Petryniak et al., 2007; Miyoshi et al., 2010; Bartolini et al.,
2013). Overexpression of Neurog2 at high levels by in utero
electroporation can induce a cortical projection neuron pheno-
type in the ventral telencephalon (Mattar et al., 2008). However,
loss of Ascl1 does not induce ectopic expression of Neurog2 or
other glutamatergic neuronal markers in the ventral telenceph-
alon, and replacement of Ascl1 by Neurog2 by a ‘‘knockin’’
method does not result in the respecification of GABAergic neu-
rons into glutamatergic neurons in the ventral telencephalon
(Parras et al., 2002). These results indicate that additional path-
ways act in parallel to those involving proneural proteins to
specify GABAergic neuron identities in the ventral telenceph-
alon, such as those involving the homeodomain transcription
factors Gsx1/2.
Although Neurog1/2 and Ascl1 have opposing cell fate speci-
fication functions in the telencephalon (glutamatergic versusGABAergic), these factors are coexpressed or sequentially ex-
pressed in the same lineage, such as in Cajal-Retzius neurons
or in postnatal-born hippocampal dentate granule cells (Kim
et al., 2007; Dixit et al., 2011). In the dorsal telencephalon,
Ascl1 is also coexpressed with Neurog1/2 by a subset of cortical
VZ and SVZ progenitors (Britz et al., 2006), albeit at lower levels
than in the ventral telencephalon, and regulates neuronal migra-
tion by activating another Rho GTPase, Rnd3 (Pacary et al.,
2011).
Olig1/2 for Oligodendrocyte Formation
Olig1/2, two closely related bHLH transcription factors, have
been identified as essential factors in the fate choice of oligoden-
drocytes (Figure 2) (Meijer et al., 2012) and also regulate their
subsequent differentiation, maturation, and myelination. Olig2
single and Olig1/2 double knockout mice lack oligodendrocyte
lineage cells (Lu et al., 2002; Zhou and Anderson, 2002; Take-
bayashi et al., 2002), whereas forced expression of Olig1/2 in
NPCs is sufficient to induce the specification of oligodendrocyte
precursor cells (OPCs) (Zhou et al., 2001; Lu et al., 2001). Olig2
functions as a repressor (Figure 3Ae) (Novitch et al., 2001;
Zhou et al., 2001) but directly activates the expression of the
oligodendrocyte-specific gene Sox10 by forming a heterodimer
with E proteins (Figure 3Ae) (Ku¨spert et al., 2011). Initial studies
analyzed the functions of Olig1/2 in the developing spinal cord
and hindbrain, where motor neurons and oligodendrocytes are
sequentially derived from common NPCs of the pMN domain
(Goulding, 2009). It was shown that Olig1 and Olig2 have over-
lapping functions in oligodendrogenesis, although Olig2 plays
a dominant role in patterning the pMN domain. In the absence
of Olig2, the formation of the pMN domain is severely dimin-
ished, and both motoneurons and oligodendrocytes are mostly
missing, indicating that Olig2 is essential for the specification
of both motoneurons and oligodendrocytes in the developing
spinal cord and hindbrain (Lu et al., 2002; Zhou and Anderson,
2002; Takebayashi et al., 2002). In the absence ofOlig1, matura-
tion of oligodendrocytes is affected (Lu et al., 2002; Xin et al.,
2005), suggesting a role for Olig1 in the differentiation process
leading to myelinating oligodendrocytes. This feature is more
apparent in response to demyelinating injury: Olig1 knockout
mice display a limited ability to repair demyelinated lesions that
were induced by gliotoxins (Arnett et al., 2004).
Functions of Olig2 in oligodendrocyte formation in the telen-
cephalon have been intensively analyzed by conditional dele-
tions at various time points during differentiation, from NPCs to
OPCs and mature oligodendrocytes, unveiling stage-specific
regulatory roles of Olig2 (Yue et al., 2006; Cai et al., 2007; Zhu
et al., 2012; Mei et al., 2013). Similar to the results in the spinal
cord and the hindbrain, Olig1 and Olig2 have nonoverlapping
roles in proliferation and differentiation of NPCs and OPCs.
Olig1 promotes the differentiation of committed OPCs, and this
function is more apparent in a repairing process than in normal
development (Arnett et al., 2004). By contrast, Olig2 functions
at earlier stages of development, promoting the fate determina-
tion to OPCs and certain types of neurons, such as cholinergic
neurons, in the telencephalon (Furusho et al., 2006).
The differentiating functions of Olig2 are regulated by post-
transcriptional modifications, especially by phosphorylation (Se-
toguchi and Kondo, 2004; Meijer et al., 2012). For example,Neuron 82, April 2, 2014 ª2014 Elsevier Inc. 13
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CK2 kinase activates the activity for generating OPCs (Huillard
et al., 2010). By contrast, serine (S147) phosphorylation in its
bHLH domain by PKA is important for motor neuron formation,
and its dephosphorylation triggers the transition from motor
neuron to oligodendrocyte formation in the pMN domain (Li
et al., 2011). This phosphorylation in the bHLH domain promotes
homodimer formation of Olig2 protein, whereas dephosphoryla-
tion promotes heterodimer formation with Neurog2 protein,
whose proneural activity is essential for motoneuron specifica-
tion. It is likely that Olig2-Neurog2 heterodimer formation
sequesters Neurog2 in the pMN domain, thereby preventing
motoneuron formation. Indeed, Olig2 mutant mice carrying a
serine-to-alanine substitution at position 147, which promoted
Olig2-Neurog2 heterodimer formation, impaired motoneuron
specification (Li et al., 2011).
At early developmental stages, Olig2 opposes differentiation
and promotes proliferation of self-renewing NPCs. This prolifer-
ative function of Olig2 is critically regulated by developmentally
controlled phosphorylation of a triple serine motif at the N-termi-
nal region. Mouse Olig2 protein is phosphorylated at these resi-
dues in NPCs during the early stage of embryos, whereas in the
postnatal white matter, the triple serine motif is nonphosphory-
lated (Sun et al., 2011). When phosphorylated at these positions,
the proliferative function of Olig2 becomes dominant over its
differentiation functions. Interestingly, this triple serine motif of
Olig2 is highly phosphorylated in malignant gliomas. These re-
sults indicate that Olig2 has contradictory functions, NPC
proliferation and oligodendrocyte formation, depending on the
phosphorylated status.
In addition to Olig1/2, it has been reported that Ascl1 also
specifies anOPCcell fate in telencephalic NPCs at later develop-
mental stages (Parras et al., 2004, 2007; Nakatani et al., 2013)
and can force an oligodendrocyte fate when overexpressed in
NPCs of the adult dentate gyrus (Jessberger et al., 2008).
Astrocyte Fate Determination
Currently, a singlemaster bHLH factor for astrocyte fate determi-
nation has not been identified, unlike proneural factors in neu-
rons and Olig factors in oligodendrocytes (Ross et al., 2003;
Namihira and Nakashima, 2013). Many studies reported the
importance of Notch signaling and downstream Hes factors as
well as Id factors in astrocyte formation, but these factors are
not sufficient for specifying embryonic NPCs into astrocytes
(Figure 3Af) (Cai et al., 2000; Ohtsuka et al., 2001; Tanigaki
et al., 2001; Wu et al., 2003; Namihira et al., 2009). For example,
overexpression of Hes or Id factors in NPCs increased the pro-
portion of astrocytes when analyzed long after the manipulation,
or promoted the formation of astrocytes in late-phase or adult
NPCs (Cai et al., 2000; Ohtsuka et al., 2001; Tanigaki et al.,
2001). However, Hes and Id fail to prematurely induce astrocyte
formation, when these factors are overexpressed at early stages
in NPCs in the developing telencephalon (Cai et al., 2000;
Ohtsuka et al., 2001). Therefore, the increased activities of
Notch-Hes and Id factors are not sufficient for astrocyte fate
determination and may permissively instruct astrocytic fate by
inhibition of the other fates, neurons, and oligodendrocytes.
Accumulating evidence indicates that extrinsic cues, such as
cytokine signaling through the JAK/STAT3 pathway and BMP14 Neuron 82, April 2, 2014 ª2014 Elsevier Inc.signaling, and epigenetic modification of astrocytic genes are
critically involved in astrocyte fate determination and differentia-
tion (Namihira and Nakashima, 2013).
The gp130-Janus kinase (JAK) is activated by leukemia
inhibitory factor (LIF) or cardiotrophin-1 (CT-1) and phosphory-
lates the downstream effector STAT3, thereby activating it.
Phosphorylated STAT3 can then directly bind to the promoter
sequences of many astrocyte genes, such as Gfap, and upregu-
late their expression (Figure 3Af). Treatment of cultured NPCs
with another group of cytokines, BMPs, can synergistically
promote astrocyte formation via the JAK-STAT pathway by acti-
vating downstream Smad transcriptional factors (Nakashima
et al., 1999). Activated Smads can form a complex with
STAT3, which is mediated by the transcriptional coactivator
p300/CBP, and participate in the induction of astrocytic
gene expression (Figure 3Af). Interestingly, this process is in-
hibited by the proneural factor Neurog1, which sequesters the
Smads-p300/CBP complex away from STAT3 (Sun et al.,
2001). Therefore, competition for limiting cofactors by fate
determination factors may be involved in mutually exclusive
cell fate choices. Indeed, astrocyte formation is ectopically
induced in compound proneural factor mutant mice (i.e.,
Neurog2;Ascl1 and Ascl1;Math3 double knockout mice) (Tomita
et al., 2000; Nieto et al., 2001). Thus, proneural factors actively
inhibit astrocyte formation, thereby reinforcing the neuronal
fate determination. Furthermore, the oligodendrocyte determi-
nation factor Olig2 is a negative regulator of astrocytic genes
and inhibits astrocyte formation in NPCs and glial-restricted
progenitors (Cai et al., 2007).
Astrocyte formation is strongly inhibited at early develop-
mental stages; combinatorial treatment of cultured NPCs with
LIF and BMP very efficiently induces astrocyte formation at
late stages but fails to do so at early stages (Nakashima et al.,
1999; Takizawa et al., 2001). This stage-dependent regulation
is achieved by epigenetic modifications, such as DNA and his-
tonemethylation. Because the promoter sequences of astrocytic
genes, includingGfap and S100b, are highly methylated in early-
stage NPCs, STAT binding to these promoters is hindered
(Takizawa et al., 2001). As the development proceeds, DNA se-
quences of astrocytic genes become demethylated and NPCs
then become responsive to astrocyte-inducing cytokines, indi-
cating that the timing of astrocyte formation during brain devel-
opment is critically regulated by DNA methylation. Various
mechanisms for regulating DNA methylation of astrocytic genes
have been revealed. For example, nuclear factor 1A/B (NFIA/B),
in cooperation with Notch signaling, plays a critical role in the de-
methylation and initiation of astrocytic gene expression (Deneen
et al., 2006; Namihira et al., 2009). Hypoxia-inducible factor
(HIF)-1a and orphan receptor Coup-TFI/II also contribute to the
demethylation of astrocytic genes during brain development
(Naka et al., 2008; Mutoh et al., 2012). In addition to DNAmethyl-
ation, histone methylation is also involved in astrocyte formation.
The H3K9 methyltransferase ESET and high mobility group A
(HMGA) proteins are known to repress accelerated astrocyte
production (Tan et al., 2012a; Kishi et al., 2012), whereas
Polycomb promotes a neurogenic to astrogenic fate transition
(Hirabayashi et al., 2009). In summary, the negative bHLH factors
Hes and Id promote astrocyte formation by inhibiting neuronal
Figure 4. Hes1 Oscillation by Negative Feedback
Figure 5. Expression Dynamics of bHLH Factors inMultipotency and
Cell Fate Choice
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inducing cytokines and epigenetic modifiers.
Expression Dynamics of bHLH Factors in Multipotency
and Cell Fate Choice
Oscillatory Expression in Multipotent NPCs
As discussed above, it has been shown that cell fate determina-
tion factors such as Ascl1, Hes1, and Olig2 have contradictory
functions: promoting NPC proliferation versus cell differentiation
(Ascl1 for neurons, Hes1 for astrocytes, and Olig2 for oligoden-
drocytes). However, the detailed mechanisms by which they
display such contradictory functions still remain to be analyzed.
It was previously shown that Hes1 expression oscillates in
many cell types (Figure 4) (Hirata et al., 2002; Masamizu et al.,
2006; Shimojo et al., 2008; Kobayashi et al., 2009). Activation
of theHes1 promoter generatesHes1mRNA and then Hes1 pro-
tein, which can repress its own expression by directly binding to
the Hes1 promoter. Due to this negative feedback, Hes1 mRNA
disappears rapidly, because it is extremely unstable. Hes1 pro-
tein is also rapidly degraded by the ubiquitin-proteasome sys-
tem, allowing the next round of activation of the Hes1 promoter.
In this way, Hes1 expression oscillates autonomously with a
period of 2 to several hours (Figure 4). Time-lapse imaging ana-
lyses using the Hes1 promoter-driven destabilized luciferase re-
porter, which monitors Hes1 mRNA production, revealed that
Hes1 mRNA expression oscillates with a period of about 2 to
3 hr in NPCs (Shimojo et al., 2008). However, because it is known
that transcription and translation can be dissociated in stem cells
(Lu et al., 2009), live imaging with new transgenic reporter mice
was employed to monitor protein expression. These reporter
mice carried a bacterial artificial chromosome (BAC) clone in
which luciferase or fluorescent cDNA was inserted into the 50 re-
gion of each factor gene so that a fusion protein was expressed.
In these reporter mice, the luciferase or fluorescent activity pre-
cisely monitors the endogenous protein expression (Imayoshi
et al., 2013). Time-lapse imaging analyses clearly showed that
Hes1 and Ascl1 protein expression oscillate with a period of
about 2 to 3 hr, while Olig2 protein expression oscillates with a
period of about 5 to 8 hr in NPCs (Figure 5). Inactivation of
Hes1 does not affect Olig2 oscillation but abolishes Ascl1 oscil-
lation. Thus, it is likely that Hes1 oscillation periodically repressesAscl1 expression, thereby driving Ascl1 oscillation, but that Olig2
expression oscillates independently of Hes1 and Ascl1 oscilla-
tion (Imayoshi et al., 2013). Together, these results indicate
that three types of cell fate determination factors are expressed
in an oscillatory manner by multipotent NPCs (Figure 5).
Sustained Expression during Cell Fate Choice
Time-lapse imaging analyses of individual cells showed that dur-
ing neuronal fate choice Ascl1 expression occurs in a sustained
manner after cell division (Figure 5) and that 6 to 8 hr later expres-
sion of the early neuronal marker Doublecortin (DCX) starts.
Ascl1 expression continues to be upregulated in many differen-
tiating cells but not in others; more than 20% of differentiating
immature neurons soon downregulate Ascl1 expression after
DCX is expressed, suggesting that the minimal requirement for
neuronal fate determination is accumulation of Ascl1 over 6 to
8 hr during G1 phase (Imayoshi et al., 2013). What causes the
transition from oscillatory to accumulative Ascl1 expression in
NPCs? During the neuronal fate choice process, the levels of
NICD, an active form of Notch signaling, fluctuate in NPCs, which
results in unstable Hes1 oscillation and even in disappearance of
Hes1 expression, leading to sustained upregulation of Ascl1.
When stable levels of NICD expression are induced in NPCs,
Hes1 oscillation continues in a stable manner, and Ascl1 expres-
sion is never upregulated. These results suggest that fluctuation
in NICD levels triggers the transition from oscillatory to sustained
Ascl1 expression (Imayoshi et al., 2013).
NPCs frequently undergo asymmetric cell division, in which
one daughter cell remains undifferentiated while the other differ-
entiates into a neuron. Before this cell division, Hes1 expression
is downregulated, and concomitantly Ascl1 expression is upre-
gulated in a sustainedmanner. Ascl1 seems to be equally distrib-
uted into both daughter cells, and the daughter NPC resumes
Hes1 and Ascl1 oscillations, whereas the daughter neuron main-
tains repressed Hes1 expression and accumulates Ascl1. Thus,
transient upregulation of Ascl1 before cell division is the first sign
for a bias toward asymmetric cell division with neuronal differen-
tiation (Imayoshi et al., 2013). However, it is not a decisive sign,
as many NPCs produce two daughter NPCs even when Ascl1 isNeuron 82, April 2, 2014 ª2014 Elsevier Inc. 15
Figure 6. Optogenetic Approach to Control Expression Dynamics
(A) hGAVPO activates gene expression by blue light illumination.
(B) The hGAVPO system shows that oscillatory expression of Ascl1 activates the proliferation of NPCs, whereas sustained expression of Ascl1 promotes neuronal
differentiation.
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cate that accumulation of Ascl1 during G1 phase is the only deci-
sive sign for neuronal fate determination.
During astrocyte and oligodendrocyte differentiation, the ex-
pressions of Hes1 and Olig2, respectively, are upregulated,
although they are still oscillatory (Figure 5). However, even during
trough phases, both Hes1 and Olig2 levels are higher than they
are in NPCs, indicating that Hes1 and Olig2 expressions
continue in a sustained manner during astrocyte and oligoden-
drocyte differentiation (Imayoshi et al., 2013). When Hes1 or
Olig2 becomes dominant, the expression of the other two factors
is downregulated. These results indicate that Ascl1, Hes1, and
Olig2 are expressed in an oscillatory manner in multipotent
NPCs and that one of them becomes dominant during cell fate
choice. Thus, the multipotent state correlates with oscillatory
expression of several fate determination factors, whereas the
differentiated state correlates with sustained expression of a
selected single factor (Figure 5).
Optogenetic Approach to Control Expression Dynamics
To address whether the correlation between expression dy-
namics (oscillatory versus sustained) and outcomes (prolifera-
tion versus differentiation) has a causative relationship, an
optogenetic approach has been employed to control the Ascl1
expression patterns. GAVPO is a light-activatable, hybrid protein
consisting of the light-inducible dimerizing protein Vivid (VVD), a
Gal4 DNA-binding domain, and a p65 transcriptional activation
domain (Figure 6A) (Wang et al., 2012). A dimer form, but not a
monomer form, of the Gal4 DNA-binding domain can interact
with UAS sequences. Blue light illumination activates VVD, form-
ing a dimer, and a dimer form of the Gal4 DNA-binding domain
binds to the UAS sequences. Then, the p65 transcriptional
activation domain upregulates the gene expression under the
control of the UAS sequences (Figure 6A). Optimizing the codon
usage of GAVPO (hGAVPO) and destabilizing the target mRNA
enable the control of dynamic gene expression (e.g., oscillatory
or sustained expression) by changing the blue light illumination
patterns. The significance of gene expression dynamics was16 Neuron 82, April 2, 2014 ª2014 Elsevier Inc.examined by introducing this Ascl1-inducible system into Ascl1
null NPCs. Light-induced sustained Ascl1 expression enhances
neuronal differentiation, whereas light-induced oscillatory Ascl1
expression with 3 hr periodicity activates proliferation of NPCs
(Figure 6B). When this system is introduced into NPCs in the dor-
sal telencephalon, sustained expression of Ascl1 increases the
number of differentiating neurons that migrate out of the ventric-
ular zone, whereas oscillatory expression of Ascl1 maintains
dividing NPCs in the ventricular zone. Thus, distinct (oscillatory
versus sustained) expression dynamics of Ascl1 are important
for the choice between proliferation and differentiation (Imayoshi
et al., 2013). Together, these data suggest that the relationship
between the gene expression dynamics of Ascl1 and its func-
tions is not just correlative but also causative and that manipula-
tion of Ascl1 expression can impose a choice favoring NPC
proliferation or neuronal differentiation according to whether
the expression is oscillatory or sustained.
The 3 hr periodicity of Ascl1 oscillation is important for NPC
proliferation, because a 6 hr period does not activate it (Imayoshi
et al., 2013). Whether the period of oscillatory expression corre-
lates with that of cell cycle remains to be determined. The
expression of bHLH factors might oscillate more slowly or
become steady in slowly cycling NPCs, and further analyses
are required to understand the significance of oscillation periods
and dynamics.
This light-inducible system can precisely change the dura-
tion of sustained Ascl1 expression to determine the minimal
requirement for the neuronal fate choice. This analysis revealed
that only 6 to 8 hr of sustained Ascl1 expression is needed to
activate neuronal differentiation (Imayoshi et al., 2013). This
agrees well with the above time-lapse imaging results showing
that the early neuronal marker expression starts after 6 to 8 hr
of sustained Ascl1 expression during the G1 phase. There may
be a critical period within the G1 phase for neuronal fate
determination, and therefore a period longer than 8 hr of sus-
tained Ascl1 expression shows a higher chance of neuronal
fate choice.
Figure 7. Three-Way Seesaw Models for
Multipotency
Oscillatory expression (A) or balanced coex-
pression (B) of three cell fate determination factors
may lead to the multipotent state.
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The above results indicate that multipotency is a state of oscilla-
tory expression of multiple fate determination factors. Inmultipo-
tent NPCs, which can generate three different cell lineages, three
types of cell fate determination factors, Ascl1, Hes1, and Olig2,
oscillate in competition with one another, in a sort of three-way
seesaw (Figure 7A). At the peak of Ascl1 oscillation, cells have
a higher tendency to differentiate into neurons, but this tendency
is not decisive; oscillating Ascl1 just maintains the potency to
generate neurons. Producing new proteins but degrading them
at once sounds like an enormous waste of energy. Why do
stem cells waste such energy? An alternative and more thrifty
way to maintain multipotency might be to repress the expression
of cell fate determination factors but keep their gene promoters
open, so that any cell fate determination factor can be expressed
when it is necessary. Such a repressive state can be induced in
NPCs at early stages by sustained Hes1 expression, which leads
to repression of other cell fate determination factors. These cells
do not differentiate into astrocytes but remain undifferentiated,
because they are epigenetically resistant to astrocyte differenti-
ation at early stages. However, as described above, cell fate
determination factors such as Ascl1 can actually promote cell-
cycle progression when they are expressed in an oscillatory
manner. Such periodic production of cell fate determination fac-
tors seems to be a driving force for cell-cycle progression,
although the exact mechanism remains to be determined.
Indeed, sustained expression of Hes1 represses proneural
gene expression and inhibits proliferation of NPCs (Baek et al.,
2006). Furthermore, in the isthmus, roof plate, and floor plate
of the developing nervous system, where Hes1 expression is
sustained, cells are negative for proneural gene expression,
and they are mostly quiescent (Baek et al., 2006). Thus, it is likely
that oscillatory expression of multiple fate determination factors
leads NPCs to actively divide, whereas sustained Hes1 expres-
sion with the concomitant sustained repression of other fate
determination factors generates quiescent NPCs. It has been
shown that sustained Hes1 expression is required for the quies-
cent state of fibroblasts and that, without Hes1, cells become
senescent, an irreversible dormant state in which cells never
enter the cell cycle (Sang et al., 2008).
Another way to maintain multipotency might be sustained and
balanced expression of three types of cell fate determination
factors, like the original seesaw model proposed for inducedNeurpluripotent stem cell (iPSC) formation
(Figure 7B) (Shu et al., 2013). Surprisingly,
in this model, co-overexpression of mes-
endodermal specifiers such as Gata6
and ectodermal specifiers such as
GMNN can counteract each other for
lineage specification, facilitate reprog-
ramming, and synergistically induce plu-ripotency (Shu et al., 2013). The mesendodermal specifiers
inhibit ectodermal specification, and the ectodermal specifiers
inhibit mesendodermal specification. When the expressions of
these two specifiers are balanced, cells cannot choose a cell
fate and are likely to enter the pluripotent state. Thus, it is
possible that balanced coexpression of Ascl1, Hes1, and Olig2
in NPCs does not enable them to choose a cell fate and may
lead to multipotency, like the original seesaw model. However,
such a balance is not robust and seems to be easily broken by
intrinsic and extrinsic fluctuating stimulants (such as fluctuating
NICD), making it difficult to maintain such a balance or the
NPC state. Thus, we speculate that although oscillatory expres-
sion of multiple cell fate determination factors may spend
enormous energy, it enables a metastable state to maintain pro-
liferative and multipotent conditions with some resistance to
fluctuating stimuli or noise.
Regulation and Function of Oscillating Factors
It is surprising that Ascl1 can have opposite functions depending
on its expression dynamics, but how the oscillatory and sus-
tained expressions of Ascl1 differentially regulate downstream
gene expression is unknown. It was reported that, depending
on the phosphorylation status, the proneural factor Neurog2 ex-
hibits different transcriptional activities in NPCs and differenti-
ating neurons (Figure 3B) (Ali et al., 2011; Hindley et al., 2012).
Ascl1 may also be differentially phosphorylated in NPCs and
neurons, thereby controlling different gene expression, although
the posttranslational regulation of Ascl1 functions remains to be
analyzed. It was reported that cell-cycle progression genes
controlled by Ascl1 have RBPjk-binding sites as well as Ascl1-
binding sites (Castro et al., 2011). Thus, Ascl1 and Notch
signaling may cooperatively activate these genes in NPCs,
although further studies are required to understand the detailed
mechanism.
The expression dynamics of Ascl1 target genes is largely un-
known. Time-lapse imaging analyses showed that Dll1 mRNA
expression, which is activated by Ascl1 and repressed by
Hes1, oscillates in NPCs but is sustained in neurons, although
it remains to be determined whether Dll1 protein expression
also oscillates in NPCs (Shimojo et al., 2008). Sustained expres-
sion of Hes1 in subsets of NPCs constitutively represses Dll1
expression, leading to inactivation of Notch signaling in neigh-
boring NPCs. This results in premature neuronal differentiation
in the VZ, suggesting that oscillatory expression of Hes1 andon 82, April 2, 2014 ª2014 Elsevier Inc. 17
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oping nervous system (Shimojo et al., 2008). Other downstream
factors may be expressed in different manners. If they are stable,
they cannot oscillate, and Hes1 and Ascl1 oscillations may lead
to accumulation of downstream factors in a stepwise manner in
NPCs. When the expression levels of such downstream factors
reach a certain value, new events might occur. In this case, infor-
mation about the number of pulses of Hes1 and Ascl1 oscilla-
tions can possibly be converted into the timing of the next event.
Such amodel was proposed for microRNA-9 (miR-9), which reg-
ulates the stability of Hes1mRNA (Bonev et al., 2012; Tan et al.,
2012b). Overexpression of miR-9 represses Hes1 expression by
destabilizing Hes1 mRNA. Because Hes1 represses miR-9 pre-
cursor expression, Hes1 oscillation drives the oscillatory expres-
sion of the miR-9 precursor. However, mature miR-9 is very
stable, and therefore the oscillatory expression of the miR-9 pre-
cursor leads to accumulation of mature miR-9 over time. It has
been proposed that this accumulation of miR-9 terminates
Hes1 expression and initiates neuronal differentiation, suggest-
ing that Hes1 oscillation functions as a timer for the switch of
neuronal differentiation (Bonev et al., 2012). Further analyses
are required to determine whether Hes1 and Ascl1 oscillations
contribute to such a cellular clock mechanism.
Direct Reprogramming of Fibroblasts to Neurons by
Proneural bHLH Factors
Direct reprogramming of the lineage of human fibroblasts into
neurons using defined combinations of transcription factors is
a promising approach for human disease modeling and regener-
ative medicine. It was thought that the lineage identity of differ-
entiated cells is very stable and that the conversion of particular
cell types across lineage boundaries is difficult due to strict chro-
matin configurations, epigenetic DNA modifications, and rein-
forced transcription factor networks. However, it has been
shown that nuclear transfer into oocytes and cell fusion can over-
come these epigenetic barriers and induce cell-fate reprogram-
ming to pluripotency (Gurdon, 2006). Reprogramming can also
be induced artificially through the introduction of exogenous fac-
tors, usually transcription factors. For instance, overexpression
of four defined factors, Oct4, Sox2, Klf4, and c-Myc, recapitu-
lates somatic cell nuclear transfer or oocyte-based reprogram-
ming to generate iPSCs (Takahashi and Yamanaka, 2006).
Direct reprogramming of adult somatic cells into alternative
cell types has been shown for several lineages, including neu-
rons (Vierbuchen et al., 2010). This approach allows the transfor-
mation of easily available somatic cell types (typically fibroblasts)
directly into neurons without transition via a pluripotent interme-
diate. It has been reported that three neuronal transcriptional
factors, Ascl1, Brn2, and Myt1l (BAM factors), are sufficient to
convert mouse fibroblasts or hepatocytes into functional neu-
rons, termed induced neuronal (iN) cells (Vierbuchen et al.,
2010). As mentioned above, the proneural bHLH factor Ascl1 is
a crucial regulator of neurogenesis during normal development.
Ascl1 is also a central and essential component of direct reprog-
ramming of mouse and human fibroblasts to iN cells (Wapinski
et al., 2013). Notably, Ascl1 is sufficient to convert mouse fibro-
blasts into immature neurons. The addition of Brn2 and Myt1l
improves the conversion efficacy and results in fully matured18 Neuron 82, April 2, 2014 ª2014 Elsevier Inc.neuronal characteristics. These factors also successfully convert
astrocytes into neurons in the mouse striatum in vivo (Torper
et al., 2013). Furthermore, overexpression of the BAM factors
converts human fibroblasts into functional neurons, albeit with
lower efficacy (Pang et al., 2011), and additional introduction of
NeuroD1 (Pang et al., 2011) or Zic1 (Qiang et al., 2011) can direct
reprogramming of human fibroblasts to functional neurons with
enhanced neuronal yield and purity. Although Ascl1 is a proneu-
ral bHLH factor regulating GABAergic neurogenesis, most of the
iN cells induced by the BAM set of transcription factors show
characteristics of glutamatergic neurons, judged by mRNA or
marker protein expression profiles and electrophysiological
properties (Vierbuchen et al., 2010). Interestingly, the combina-
torial use of two proneural bHLH factors, Ascl1 and Neurog2, re-
sults in more efficacious reprogramming than the use of the BAM
factors, but iN cells induced by Ascl1 and Neurog2 exhibit mix-
tures of glutamatergic and GABAergic neurons (Ladewig et al.,
2012). Another combination of Ascl1 and the SRY-box factor
Sox2 more predominantly converts pericytes into GABAergic
neurons (Karow et al., 2012). Direct lineage reprogramming
approaches have been also applied to other specific neuronal
subtypes, such as dopaminergic neurons (Caiazzo et al., 2011;
Pfisterer et al., 2011). In the in vivo brain, the same factor can
induce different neuronal subtypes, depending on the environ-
mental condition: Neurog2 can induce GABAergic neurons in
the striatum and glutamatergic neurons in the neocortex (Grande
et al., 2013). Despite these intensive studies, the generation of iN
cells by current protocols is relatively inefficacious, and the het-
erogeneity of the induced cells and limited scalability to obtain
postmitotic neurons need to be improved.
Many of the underlying mechanisms by which these reprog-
ramming processes can be induced by just a small number of
transcriptional factors, remain obscure. To improve the efficacy
and purity of direct reprogramming to neurons, it is essential to
fully characterize the mechanisms by which reprogramming fac-
tors, including Ascl1, Neurog2, or NeuroD1 bHLH factors,
contribute to this process. Recent integrative genomic analysis
of fibroblasts-to-iN cell reprogramming using the BAM factors
revealed the ‘‘on-target pioneer factor’’ activity of Ascl1 (Wapin-
ski et al., 2013). Ascl1 can access nucleosomal DNA and imme-
diately bind to its authentic neurogenic target genes across the
fibroblast genome. Ascl1 seems to be able to bind to its target
genes and activate their expression irrespective of whether
genomic sites are freely available or are nucleosome bound.
This study also discovered the specific chromatin configurations
that favor access of Ascl1 to its target sites.
In addition to direct reprogramming to neurons, direct conver-
sion to oligodendrocyte precursor cells (OPCs) or NPCs have
been reported (Najm et al., 2013; Yang et al., 2013). In OPC re-
programming studies, Olig2 and Sox10, both of which play
essential roles in oligodendrocyte formation during normal
development, are used as the core components of reprogram-
ming factors. Many methods and protocols of direct reprogram-
ming to NPCs have been also reported, and similar to other
lineage reprogramming, transcription factors that are important
for achieving and maintaining cell-type-specific identity during
normal development function as the core component of reprog-
ramming cocktails. Sox2 is a central and essential component of
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efficacy is promoted by combinatorial induction of other factors,
such as FoxG1, Brn2/4, Klf4, and c-Myc (Yang et al., 2011).
Most protocols for direct cellular reprogramming are currently
based on cotransduction of multiple lentiviral vectors having
constitutively active promoters. Therefore, reprogramming fac-
tors are usually overexpressed throughout all reprogramming
processes, although conditional expression using the Tet sys-
tem has also been tried. As mentioned above, the expression
and activity of many transcription factors regulating NPCs are
dynamically regulated, and these dynamic regulations are critical
for self-renewal, multipotency, and fate choice of NPCs (Im-
ayoshi et al., 2013). For example, the proneural bHLH factors
Neurog2 and Ascl1 are transiently expressed in NPCs and imma-
ture neurons, but their expression is rapidly downregulated
during neuronal maturation. Prolonged expression of these
fate-determination factors is inhibitory to maturation and even
toxic to differentiated cells. Indeed, one important problem to
be overcome is that most reprogrammed neural cells, including
iN cells, are phenotypically immature, and the proportion of fully
matured cells is very low (Yang et al., 2011). These problems
might be resolved by developing reprogramming protocols that
manipulate the mode, order, and magnitude of expression, as
well as the activity of transcription factors by recapitulating their
dynamic regulation during normal development. Furthermore,
oscillating expression of bHLH factors, including Hes, Ascl1,
Neurog2, and Olig2, in NPCs is important for forming a meta-
stable state that maintains their proliferative and multipotent
potentials. Therefore, inducing oscillatory and transiently accu-
mulative expression (e.g., by a light-inducible expression sys-
tem) may greatly improve the low conversion efficacy of direct
cellular reprogramming of neural cells.
Conclusions and Perspectives
It is now clear that bHLH factors have multiple functions that are
controlled by posttranslational modifications and expression dy-
namics. Particularly, the proneural bHLH factor Ascl1 exhibits
contradictory functions (NPC proliferation versus neuronal differ-
entiation) when the expression is oscillatory or sustained. It is
likely that Hes1 and Olig2 also have such contradictory functions
depending on their expression dynamics. One important ques-
tion here is how genes involved in cell-cycle progression are
activated by bHLH factors like Ascl1 when the expression is
oscillating but repressed by the same bHLH factors when the
expression is sustained. The presence or absence of NICD
may be one such mechanism because RBPjk-binding sites are
present in the promoters of genes involved in cell-cycle progres-
sion, but further studies are definitely required to understand the
precise mechanisms for such differential gene regulations. For
the purpose of efficacious reprogramming to generate mature
neurons or oligodendrocytes, time-controlled oscillatory and
sustained expression of bHLH factors may be important, and
recent emerging optogenetic technologies will be advantageous
to precisely recapitulate such expression patterns.
Another issue is that NPCs change their competency during
neocortical development; lower-layer neurons are generated
first, then upper-layer neurons, and lastly glial cells. It is known
that the epigenetic status, such as their DNA methylation andhistone modifications, changes over time in NPCs, leading to
different competencies, but the mechanisms of such time-
dependent changes are unknown. Oscillatory bHLH factors
might lead to gradual upregulation or downregulation of the
expression of their target genes, which might affect their epige-
netic status. In this case, oscillatory bHLH factors may function
as an internal clock in NPCs, but this possibility remains to be
addressed.
Neurogenesis occurs continuously in the adult brain and plays
an important role in higher brain functions such as learning and
memory. Reduced neurogenesis in the adult brain results in brain
dysfunctions such as memory defects and depression. Unlike
embryonic NPCs, adult NPCs are slowly dividing or quiescent
and only occasionally divide to give rise to new neurons. It was
found that the same bHLH factors (i.e., Hes1 and Ascl1) are ex-
pressed byNPCs and differentiating neurons, respectively, in the
adult brain. An emerging question is how Hes1 and Ascl1 regu-
late the maintenance of active embryonic NPCs and dormant
adult NPCs. One possible mechanism might be their different
expression dynamics in embryonic and adult NPCs. Hes1 and
Ascl1 expression oscillates in embryonic NPCs but might be
nonoscillatory in adult NPCs. Clearly, further studies are required
to test this model, and if this is the case, it will be important to
test the idea whether forced oscillatory expression of Hes1 and
Ascl1 can transform dormant NPCs into active NPCs. Further
understanding of developmental mechanisms will be helpful to
develop new methods for the effective generation of neurons,
which are applicable to regenerative medicine.
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